Literature DB >> 21773908

Living-donor lobar lung transplantation for pulmonary alveolar proteinosis in an adult: report of a case.

Tsutomu Tagawa1, Naoya Yamasaki, Tomoshi Tsuchiya, Takuro Miyazaki, Kei Matsuki, Yoshiko Tsuchihashi, Konosuke Morimoto, Takeshi Nagayasu.   

Abstract

A 43-year-old woman with pulmonary alveolar proteinosis (PAP) was successfully treated with living-donor lobar lung transplantation (LDLLT). The patient's PAP had been diagnosed at age 35. She had been treated with repeated bronchoalveolar lavage and granulocyte-macrophage colony-stimulating factor (GM-CSF) inhalation therapy despite having no serum anti-GM-CSF autoantibodies. At age 42, her respiratory condition became critical and she underwent transplantation from two donors. While careful observation was needed for the recurrence of PAP in the transplanted lungs, she was functioning well without oxygen therapy 1 year after transplantation. This appears to be the first report of LDLLT for PAP in an adult.

Entities:  

Mesh：

Year:  2011        PMID： 21773908     DOI： 10.1007/s00595-010-4411-0

Source DB:  PubMed          Journal:  Surg Today        ISSN： 0941-1291            Impact factor:   2.549


  6 in total

1.  International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.

Authors:  Jonathan B Orens; Marc Estenne; Selim Arcasoy; John V Conte; Paul Corris; Jim J Egan; Thomas Egan; Shaf Keshavjee; Christiane Knoop; Robert Kotloff; Fernando J Martinez; Steven Nathan; Scott Palmer; Alec Patterson; Lianne Singer; Gregory Snell; Sean Studer; J L Vachiery; Allan R Glanville
Journal:  J Heart Lung Transplant       Date:  2006-07       Impact factor: 10.247

2.  The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009.

Authors:  Jason D Christie; Leah B Edwards; Paul Aurora; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Josef Stehlik; David O Taylor; Anna Y Kucheryavaya; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2009-10       Impact factor: 10.247

3.  Pulmonary alveolar proteinosis: lung transplant or bone marrow transplant?

Authors:  S P Gaine; A S O'Marcaigh
Journal:  Chest       Date:  1998-02       Impact factor: 9.410

4.  Recurrent alveolar proteinosis following double lung transplantation.

Authors:  L A Parker; D B Novotny
Journal:  Chest       Date:  1997-05       Impact factor: 9.410

Review 5.  Pulmonary alveolar proteinosis.

Authors:  O C Ioachimescu; M S Kavuru
Journal:  Chron Respir Dis       Date:  2006       Impact factor: 2.444

6.  Lung transplantation in children.

Authors:  Charles B Huddleston; Jeffrey B Bloch; Stuart C Sweet; Maite de la Morena; G Alexander Patterson; Eric N Mendeloff
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969
  6 in total
  2 in total

1.  Incidence and pattern of hemolytic anemia after minor ABO-mismatched living-donor lobar lung transplantation.

Authors:  Akihiro Ohsumi; Fengshi Chen; Kimiko Yurugi; Taira Maekawa; Tsuyoshi Shoji; Masaaki Sato; Akihiro Aoyama; Toru Bando; Hiroshi Date
Journal:  Surg Today       Date:  2012-11-23       Impact factor: 2.549

2.  Recurrence of pulmonary alveolar proteinosis after bilateral lung transplantation in a patient with a nonsense mutation in CSF2RB.

Authors:  Masahiro Takaki; Takeshi Tanaka; Yoshihiro Komohara; Yoshiko Tsuchihashi; Daisuke Mori; Kentaro Hayashi; Junya Fukuoka; Naoya Yamasaki; Takeshi Nagayasu; Koya Ariyoshi; Konosuke Morimoto; Koh Nakata
Journal:  Respir Med Case Rep       Date:  2016-08-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.